Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Bioconjug Chem. 2021 Jan 20;32(1):82-87. doi: 10.1021/acs.bioconjchem.0c00557. Epub 2020 Dec 9.
Since its conception, the ribonuclease S complex (RNase S) has led to historic discoveries in protein chemistry, enzymology, and related fields. Derived by the proteolytic cleavage of a single peptide bond in bovine pancreatic ribonuclease (RNase A), RNase S serves as a convenient and reliable model system for incorporating unlimited functionality into an enzyme. Applications of the RNase S system in biomedicine and biotechnology have, however, been hindered by two shortcomings: (1) the bovine-derived enzyme could elicit an immune response in humans, and (2) the complex is susceptible to dissociation. Here, we have addressed both limitations in the first semisynthesis of an RNase S conjugate derived from human pancreatic ribonuclease and stabilized by a covalent interfragment cross-link. We anticipate that this strategy will enable unprecedented applications of the "RNase-S" system.
自其概念提出以来,核糖核酸酶 S 复合物(RNase S)在蛋白质化学、酶学及相关领域引发了历史性的发现。RNase S 是通过牛胰腺核糖核酸酶(RNase A)中的单个肽键的蛋白水解切割而衍生出来的,它是一种将无限功能整合到酶中的方便可靠的模型系统。然而,RNase S 系统在生物医药和生物技术中的应用受到两个缺点的阻碍:(1)牛源酶可能会在人体内引发免疫反应,(2)该复合物易发生解离。在这里,我们在首例源自人胰腺核糖核酸酶的 RNase S 缀合物的半合成中解决了这两个限制,并通过共价片段间交联进行稳定。我们预计,该策略将使“RNase-S”系统能够实现前所未有的应用。